Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While GHRP-2 is used in research to induce robust GH pulses and study anabolic and metabolic effects; clinically developed as pralmorelin for GH deficiency diagnostics6272, Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92.
While GHRP-2 works as a second-generation hexapeptide growth hormone–releasing peptide that mimics ghrelin by agonizing GHSR-1a, strongly stimulating pulsatile GH release and modestly raising prolactin, ACTH, and cortisol62723096, Setmelanotide is a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100.
GHRP-2
GHSR
Setmelanotide
POMC
The clearest overlap between GHRP-2 and Setmelanotide is that both converge around Receptor agonist. Both are often discussed in Metabolic and endocrine contexts, while GHRP-2 is more of a hormone peptide and Setmelanotide is better described as a metabolic peptide and Neuropeptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with GHRP-2 leaning toward Anabolic growth and Setmelanotide leaning toward Metabolic regulation. Both are synthetic in origin and their development context also differs, with GHRP-2 in Clinical phase 1 while Setmelanotide is approved. GHRP-2 takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide.
No related articles are linked to these peptides yet.